J&J MedTech appoints new ANZ leader

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and New Zealand, effective 28 October 2024. Sarah Najdek transitions into this role from her current position as Vice President of Cardiovascular Specialty Solutions Group, APAC, at Johnson & Johnson MedTech, which she has held over the past year.

Najdek succeeds Sue Martin, whose departure marks the end of a distinguished 23-year career at Johnson & Johnson, including seven years leading J&J MedTech across Australia and New Zealand.

“Sarah steps into this role after most recently leading the Electrophysiology, Neurovascular, and Mentor business unit in Asia Pacific. Sarah has consistently proven herself to be a customer-centric, tenacious leader with a strong bias for action and an exceptional ability to bring people together,” the company said in a statement.

A seasoned and commercially astute leader, Najdek brings over 20 years of strategic management experience across the manufacturing, medical device, and pharmaceutical industries in New Zealand, Australia, and Asia Pacific. In addition to her previous role as General Manager & Country Director for Johnson & Johnson MedTech New Zealand, she has served on the board of Johnson & Johnson MedTech ANZ and the Medical Technology Association of New Zealand (MTANZ).

Her career with Johnson & Johnson MedTech and Janssen has seen her hold senior leadership positions in diverse areas such as General Surgery, Bariatrics, Orthopaedics, Diabetes Management, Oncology, Immunology, and Medical Affairs. A passionate advocate for women in leadership, Najdek was also a founding member of J&J’s ANZ Diversity and Inclusion strategy committee.

In related news, Johnson & Johnson has announced that its medtech businesses – Ethicon, DePuy Synthes, Biosense Webster, Abiomed and CERENOVUS – will now operate under the unified name Johnson & Johnson MedTech. This is the next step of Johnson & Johnson’s updated brand and visual identity announced in September 2023.

In reimagining healthcare, Health Industry Hub^TM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.